BioNTech Is Riding A Wave Of COVID-19 Vaccine Demand, But How Long Will It Last?

Company Will Earn Nearly $20bn In 2021

 
• By Andrew McConaghie
  
Stafford / United Kingdom - November 9 2020: Pfizer BioNTech Covid-19 vaccine concept. Syringe balanced on a fingertip and blurred company logos on the background. Selective focus.
Pfizer and BioNTech now expect to deliver 2.5 billion doses of Comirnaty this year, putting them far ahead of mRNA vaccine rivals Moderna. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip